newsfilter
← Latest News
GlobeNewswire·

VectivBio Appoints Patrick Malloy as Senior Vice President, Investor Relations & Strategic Communications

BASEL, Switzerland, April 21, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG ("VectivBio") (NASDAQ:VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the appointment